Early research (Phase 1)Active Not RecruitingNCT01683279
What this trial is testing
A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia
Who this might be right for
B Cell Leukemia
Seattle Children's Hospital 6